KIN Analysis

Kindred Biosciences, Inc.
Delisted 2021-08-27
Stock Exchange: NASDAQ
Sector: healthcare
9.25
Last session price
9.25
Price now
Currency: USD
Reporting currency: USD
ISIN: US4945771099
INN:
.

KIN financial statements

* Numbers in thousands
Capitalization * 363 423
EV * 205 263
Number of shares * 39 289
EPS -0,55
Revenue * 42 164
Net income * -21 796
Operating profit * -15 722
Total liabilities * 28 332
Net debt * 8 818
Total assets * 95 814
Equity * 67 482
Cash and investments * 58 378
.

KIN valuation

P/E -16,67
P/B 5,39
P/S 8,62
E/P -6
P/FCF -26,93
.

KIN profitability

ROE -32%
ROA% -23%
ROIC% -18%